Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Two Batches of Tamsulosin Hydrochloride 0.4-mg Capsules
NCT02266511Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 1999
- Primary completion
- Sep 1999
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of tamsulosin in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area under the concentration-time curve, Maximum concentration and 7 more. Started Aug 1999; status: completed.
02
Drugs
tamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT02266511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02266511.